UNII EX438O2MRT

FERRIC OXIDE YELLOW

Unique Ingredient Identifier EX438O2MRT is listed as a ingredient substance
UniiEX438O2MRT
Preferred Substance NameFERRIC OXIDE YELLOW
Rn51274-00-1
Ec257-098-5
NcitC75671
Rxcui1305582
Molecular FormulaFe.O.HO.H2O
InchikeyLDHBWEYLDHLIBQ-UHFFFAOYSA-M
SmilesO.[OH-].[O--].[Fe+3]
Unii TypeINGREDIENT SUBSTANCE
RN51274-00-1
EC257-098-5
NCITC75671
RXCUI1305582
MFFe.O.HO.H2O
INCHI KEYLDHBWEYLDHLIBQ-UHFFFAOYSA-M
SMILESO.[OH-].[O--].[Fe+3]

Alternate Names

Dosage Forms

UNII EX438O2MRT FERRIC OXIDE YELLOW is commonly included in medications in the following forms.

RouteDosage FormPotency
BUCCALFILM0.27 MG
BUCCALTABLET1 MG
INHALATIONPOWDER0.04 MG
ORALCAPSULE1.05 MG
ORALCAPSULE (IMMED./COMP. RELEASE) NA
ORALCAPSULE (IMMED./COMP. RELEASE), HARD GELATIN0.17 MG
ORALCAPSULE, COATED0.0115 MG
ORALCAPSULE, DELAYED ACTION0.68 MG
ORALCAPSULE, DELAYED ACTION, ENTERIC COATED NA
ORALCAPSULE, DELAYED RELEASE0.42 MG
ORALCAPSULE, ENTERIC COATED PELLETS NA
ORALCAPSULE, EXTENDED RELEASE1.67 MG
ORALCAPSULE, HARD GELATIN0.41 MG
ORALCAPSULE, SOFT GELATIN1.23 MG
ORALCAPSULE, SOFT GELATIN LIQUID-FILLED0.1 MG
ORALCAPSULE, SUSTAINED ACTION3.04 MG
ORALGRANULE, FOR ORAL SUSPENSION1.8 MG
ORALGRANULE, FOR RECONSTITUTION0.25 MG
ORALPELLET1.8 MG
ORALPOWDER, FOR ORAL SOLUTION0.38 MG
ORALPOWDER, FOR SUSPENSION0.45 g
ORALSOFT CAPSULE DOSAGE FORM0.123 mg
ORALSUSPENSION, SUSTAINED ACTION0.04 MG/.20684GM
ORALTABLET0.24 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED2.02 MG
ORALTABLET, CHEWABLE0.7 mg
ORALTABLET, COATED0.38 MG
ORALTABLET, CONTROLLED RELEASE0.93 MG
ORALTABLET, DELAYED ACTION0.4 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED0.43 MG
ORALTABLET, DELAYED RELEASE0.2 mg
ORALTABLET, EXTENDED RELEASE3 MG
ORALTABLET, FILM COATED11.5 MG
ORALTABLET, FILM COATED, EXTENDED RELEASE2.42 MG
ORALTABLET, MULTILAYER, EXTENDED RELEASE1.96 MG
ORALTABLET, ORALLY DISINTEGRATING1.5 MG
ORALTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE0.32 mg
ORALTABLET, SUSTAINED ACTION3 MG
ORALTABLET, SUSTAINED ACTION, FILM COATED0.065 MG
ORAL-20TABLET2 mg
SUBLINGUALTABLET1 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.